Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

MARCAINE Drug Profile

« Back to Dashboard

What is the patent landscape for Marcaine, and when can generics launch?

Marcaine is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in MARCAINE is bupivacaine hydrochloride; epinephrine bitartrate. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.

Summary for Tradename: MARCAINE

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list62
Clinical Trials: see list116
Patent Applications: see list6,567
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MARCAINE at DailyMed

Pharmacology for Tradename: MARCAINE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
MARCAINE
bupivacaine hydrochloride
INJECTABLE;SPINAL018692-001May 4, 1984APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION016964-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION016964-012Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION016964-008Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE
bupivacaine hydrochloride
INJECTABLE;INJECTION016964-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot